Ronald W Eastman's Net Worth
$19.7 Thousand
Who is Ronald W Eastman?
Ronald W Eastman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Corium International, Inc., Revance Therapeutics, Inc., Bioventus Inc., pSivida Corp., BioPlus Acquisition Corp., and Epiphany Technology Acquisition Corp..
SEC CIK
Ronald W Eastman's CIK is 0001597585
Past Insider Trading and Trends
2017 was Ronald W Eastman's most active year for acquiring shares with 3 total transactions. Ronald W Eastman's most active month to acquire stocks was the month of April. 2018 was Ronald W Eastman's most active year for disposing of shares, totalling 3 transactions. Ronald W Eastman's most active month to dispose stocks was the month of October. 2015 saw Ronald W Eastman paying a total of $0.00 for 28,000 shares, this is the most they've acquired in one year. In 2018 Ronald W Eastman cashed out on 50,000 shares for a total of $625,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Corium International, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -9.35M |
$12.50 | -$116,916,300.00 |
0
|
Nov 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
∞
| 9.35M |
$8.00 |
—
| 9.35M |
Apr 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Revance Therapeutics, Inc. (RVNC) Snapshot price: $6.56
InvestorRonald W Eastman owns 3,000 units of Common Stock which is worth $19,680.00.acquired a total of 3,000 shares in Revance Therapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3K |
—
|
—
| 3K |
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8
| |||
Form 4
|
∞
| 4.13M |
—
|
—
| 4.13M |
Feb 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Bioventus Inc. (BVS) Snapshot price: $9.54
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
pSivida Corp. (EYPT) Snapshot price: $7.97
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BioPlus Acquisition Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |